Cargando…
Pharmaceutical “New Prior Knowledge”: Twenty-First Century Assurance of Therapeutic Equivalence
Facilitating utility of prior knowledge to accelerate evidence-based new drug development is a focus of several communities of knowledge, such as clinical pharmacology. For example, progress has been made via modeling and simulation of pharmacokinetic and pharmacodynamic relationships in the more ef...
Autores principales: | Hussain, Ajaz S., Gurvich, Vadim J., Morris, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439171/ https://www.ncbi.nlm.nih.gov/pubmed/30868291 http://dx.doi.org/10.1208/s12249-019-1347-6 |
Ejemplares similares
-
In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs
por: Gurvich, Vadim J., et al.
Publicado: (2020) -
First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing
por: Zaborenko, Nikolay, et al.
Publicado: (2019) -
Pharmaceutical Quality, Team Science, and Education Themes: Observations and Commentary on a Remarkable AAPS PharmSciTech Theme Issue
por: Hussain, Ajaz S., et al.
Publicado: (2021) -
Science‐Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical Labels
por: Bowman, Christopher J., et al.
Publicado: (2022) -
Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
por: Frechen, Sebastian, et al.
Publicado: (2022)